S Samuel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S Samuel

Showing results (711-720 of 713) with videos related to

Pageof 72

Sort By:

You have reached the last page of results.This site can display upto 713 results.

Science Advances|September 29, 2021

Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin statusKendelle J Murphy, Daniel A Reed, Claire Vennin, et al.

Science Translational Medicine|April 7, 2017

Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasisClaire Vennin, Venessa T Chin, Sean C Warren, et al.

Science Advances|July 3, 2024

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.

Pageof 72

Search research articles

Showing results (711-720 of 713) with videos related to

Sort By:

Pageof 72

You have reached the last page of results.This site can display upto 713 results.

Science Advances|September 29, 2021

Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin statusKendelle J Murphy, Daniel A Reed, Claire Vennin, et al.

Science Translational Medicine|April 7, 2017

Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasisClaire Vennin, Venessa T Chin, Sean C Warren, et al.

Science Advances|July 3, 2024

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.

Pageof 72